This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Synovus Sale Faces Hurdles: Analysts

NEW YORK ( TheStreet) -- Synovus Financial's (SNV - Get Report) reported plans to consider exploring a sale or merger may be challenging and will not likely translate into a premium for shareholders, according to analysts.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Synovus stock was down from $2.65 at the beginning of the week to $2.50 Thursday at close.

"The market's translation is that the buyers have put substantial marks on the loan portfolio," said Adam Barkstrom, managing director of equity research at Sterne Agee. "I think some [potential acquirers] might be concerned about the loan portfolio, which means getting a deal done will be more of a challenge."

Barkstrom added that a bidder would likely take a markdown of 12 percent in any purchase, similar to the Bank of Montreal (BMO - Get Report) acquisition of Marshall & Ilsley Corp. (MI).

In addition, any buyer would also have to pay back the back the $967.9 million in bailout funds Synovus received through the Troubled Assets Relief Program, or TARP.

Synovus has a price target of $2.60 a share, with normalized earnings power of 25 cents a share, according to Brian Foran, an analyst at Nomura. Foran estimates that the bank could sell for a valuation of $3 a share or 1.1 times tangible book, similar to the BMO and M&I tie-up.

Bidders for the bank could include BB&T Corp. (BBT - Get Report), JPMorgan Chase (JPM - Get Report), Iberiabank Corporation (IBKC), Toronto-Dominion Bank (SNV - Get Report) and Royal Bank of Canada (RY - Get Report), according to analysts.

Barkstrom believes that strategically Synovus would fit with BB&T, but it may be weary of the tangible capital errosion any acquisition may bring.

"It was long rumored that SunTrust (STI - Get Report)would be great with JPMorgan, but they don't want to sell," said Barkstrom adding that there also may be regulatory objection to a JPMorgan/SunTrust merger. "Synovus is like a mini-SunTrust."

JPMorgan has acted as an advisor for Synovus in the past and CEO Jamie Dimon mentioned during the bank's investor conference that it may make opportune acquisitions.

The Canadian banks like RBC may have the most appetite for an acquisition, but the bank would have to endure a negative reaction from the marketplace that would be likely to follow, according to published reports.

Calls to Synovus for comment were not returned immediately returned.

--Written by Maria Woehr in New York.

To contact the writer of this article, click here: Maria Woehr.

To follow the writer on Twitter, go to

To submit a news tip, send an email to:

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BMO $62.37 -0.46%
BBT $34.01 0.03%
JPM $61.60 0.59%
SNV $29.95 0.57%
RY $58.90 0.19%


Chart of I:DJI
DOW 17,740.63 +79.92 0.45%
S&P 500 2,057.14 +6.51 0.32%
NASDAQ 4,736.1550 +19.0610 0.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs